Breaking News on Pharmaceutical Technology

Latest news headlines

Products

Suppliers

AMRI upbeat for 2010 despite drop in Q1 revs

06-May-2010 - Albany Molecular Research (AMRI) says Q1 decline is due to “soft” demand for contract manufacturing services and trial materials, but is still confident of full-year growth.

News in brief

APC unveils plant expansion plans at BIO 2010

05-May-2010 - The American Peptide Company (APC) says extra capacity at its protein production plant in Vista, California will help meet customer demand for large volume manufacturing.

DSM joins with Australian government for biologics plant

03-May-2010 - DSM Biologics has entered into a partnership with the Australian government to build a 70,000 sq ft biopharmaceutical contract manufacturing facility.

Chao Center to close; replacement Seromycin maker required

28-Apr-2010 - The Chao Center for Industrial research and contract manufacturing is to close this year after failing to become a self sustaining enterprise.

New Xcellerex CEO targets growth in revenues, clients

26-Apr-2010 - The incoming Xcellerex CEO plans to move the company from validation to penetration, boosting revenues and client base, and invest in the contract manufacturing side of the business.

Map of India’s bulk drug and formulation facilities

19-Apr-2010 - in-PharmaTechnologist presents exclusive interactive maps of pharma manufacturing facilities in India, detailing the number of bulk drug and formulation facilities in each region of the country.

DPT, NextPharma and Vetter update on sterile production expansions

08-Apr-2010 - The drug industry will gain new options for sterile contract development and manufacturing in the near future with DPT Laboratories, NextPharma and Vetter each working on new dedicated units.

News in brief

Dishman plans new plants to “bridge gap” with larger rivals

07-Apr-2010 - Indian CMO Dishman Pharmaceuticals and Chemicals will invest around INR1bn (€16.7m) to build four new manufacturing facilities near its existing production sites in Ahmedabad.

SAFC opens $30m expansion of HPAPI production site

06-Apr-2010 - SAFC has opened the $30m (€22m) expansion of a US production facility, adding HPAPI capacity to meet rising demand for Phase III and commercial manufacturing services.

Hyde opens European office

01-Apr-2010 - Hyde Engineering + Consulting has opened an office in Dublin, Ireland, enhancing its ability to provide Europe-based biopharm with compliance, qualification and automation services.

Thermo takes over trial supply production at Lilly Indy plant

29-Mar-2010 - Thermo Fisher Scientific will take charge of clinical trial material production at Eli Lilly’s research technology facility in Indianapolis as the pharmaceutical firm further reduces in-house capacity to cut costs.

DPT says centres of excellence boost efficiency

22-Mar-2010 - New specialist development and manufacturing “centres of excellence” increase efficiencies and customer access to expertise, DPT Laboratories spokesman tells Outsourcing-pharma.

Patheon posts Q1 loss, but upbeat on 2010; Orexigen deal

16-Mar-2010 - Patheon attributes Q1 loss to charges and plant closure costs and says there has been “an encouraging increase in new sales activity” in calendar 2010.

Sigma adds big name small molecules to portfolio in Pfizer deal

15-Mar-2010 - Drug researchers will have greater access to some top selling molecules, including currently patented compounds atorvastatin, sildenafil and celecoxib, thanks to Sigma Aldrich’s new bioactives deal with US drug major Pfizer.

China to build ‘one of largest biologics CMOs in Asia’

15-Mar-2010 - The Chinese government is supporting a $100m (€73m) project to build a contract biologics production facility in Beijing, which, by some measures, would be the largest in Asia.

Genewiz adds gene synthesis

11-Mar-2010 - DNA sequencing specialist Genewiz has added gene synthesis to its service portfolio, providing researchers with a time- and cost-saving alternative to techniques such as molecular cloning and protein engineering.

AuroSource joins India’s $1.5bn CRAMS sector

08-Mar-2010 - Indian generic drugmaker Aurobindo Pharma officially launched its CRAMS unit AuroSource last week, also unveiling plans for an R&D facility in Pashamylaram near Hyderabad, India.

Excella teams with Atacama on “revolutionary” PDG tech

04-Mar-2010 - German contract manufacturing organisation (CMO) Excella will provide pneumatic dry granulation (PDG) tablet making services through a new partnership with Finnish specialty pharmaceutical firm Atacama Labs.

BTS opens Singapore consulting office

03-Mar-2010 - Bayer Technology Services (BTS) has set up a new Singapore office to provide the regions’ drug and chemicals producers with engineering consultation services and micro reaction technology.

Watson to sell ScinoPharm share to Uni-President

02-Mar-2010 - A significant share of contract API maker ScinoPharm Taiwan is set to change hands after Watson Pharmaceuticals decided to sell its stake to Uni-President Enterprises Corporation.

FDA OK for Haupt Pharma’s Italian antibiotics plant

01-Mar-2010 - US FDA clearance for Italian antibiotics production facility is important for global growth says German contract development and manufacturing organisation (CDMO) Haupt Pharma.

News in brief

Aurelius buys fine chemicals supplier Isochem

01-Mar-2010 - German investment group Aurelius AG has acquired French fine chemicals supplier Isochem from state owned firm Groupe SNPE.

Small firms turning to US CMOs in downturn; SOCMA

24-Feb-2010 - In the economic downturn biotechs have cut back on outsourcing to Asia and opted to use the US instead because they lack the resources to manage overseas relationships, according to a SOCMA representative.

Helvoet to build parenteral component plant in India

23-Feb-2010 - Helvoet Pharma is to build a €14m ($19m) rubber parenteral packaging component facility in India to meet rising demand for products made to international quality standards.

Dishman teams with Codexis’ for cost saving enzymatic API tech

23-Feb-2010 - Codexis’ enzymatic biocatalysis technology offers numerous processing and cost advantages for API and chemical intermediate manufacture says Dishman CRAMS unit president Nick Green.

Sign up for your free newsletter